And it’s back! Recent developments in Congress deserve to turn our attention to OTC Monograph Reform one more time. This document is strictly important for the cosmetic companies with over-the-counter drug products. In this session, we will discuss why OTC reform is necessary and how the legislation will impact the OTC monograph system and will check potential outcomes.
Check out the incredible speaker line-up to see who will be joining Vidita.
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.